4//SEC Filing
Onaitis Matthew 4
Accession 0001209191-12-000914
CIK 0001339455other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 1:50 PM ET
Size
5.3 KB
Accession
0001209191-12-000914
Insider Transaction Report
Form 4
Onaitis Matthew
VP, General Counsel
Transactions
- Sale
Common Stock
2012-01-03$0.48/sh−9,000$4,290→ 155,037 total
Footnotes (2)
- [F1]This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person with the proceeds remitted to the Company to cover the taxes withheld upon the vesting of 10,000 restricted stock units on December 31, 2011 and 10,000 restricted stock units on January 1, 2012.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4501 to $0.498, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeother
Related Parties
1- filerCIK 0001362822
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 1:50 PM ET
- Size
- 5.3 KB